Researchers Found NYCs COVID-19 Origins

Sep, 2020 - by CMI

Researchers Found NYCs COVID-19 Origins

The new research offers unexpected insights about the diversity and origin of the novel coronavirus pathogen.

The research team from the Icahn School of Medicine at Mount Sinai suggests that the COVID-19 outbreak in New York City had stemmed primarily from the United States and European descents. The research was published in May 2020 in the Science Journal. However, it is the first research to trace the origins of the novel coronavirus (COVID-19 pandemic) outbreak in New York City. With limited evidence, the researchers have shown that the NYC COVID-19 outbreak had stemmed from Europe and America.

The team has also examined early community dissemination of the novel coronavirus named SARS-CoV-2 in NYC during this research. The novel coronavirus was first reported to the World Health Organization (WHO) on December 31, 2019, when several individuals of Wuhan, China contracted the virus. To date, the virus has infected more than 6.26 million individuals across the globe and has killed more than 375,513 people around the world. In recent history, this has been one of the worst pandemics to hit the world. New York City epicenters of the COVID-19 infection in the United States. Until now, the virus has killed more than 17,000 individuals in the metropolitan area.

Knowing when the virus arrived in the city and the route it took is critical to the evaluation and design of assessment strategies. The researchers sequenced the patients those who receiving care at a hospital in Mount Sinai. The analysis indicated around 84 different SARS-CoV2 genomes mainly from the other parts of the U. S. and Europe. Moreover, the researchers found the groups of related viruses in various neighborhoods and suggested that by March 18, the virus had been spread in the community. The new research offers unexpected insights about the diversity and origin of the novel coronavirus pathogen. The research also highlighted the need for initial response in the event of an emerging pathogen.